Epstein-Barr virus antibodies in multiple sclerosis

Archives of Neurology
|February 1, 1980
PubMed

Insights

Patients with multiple sclerosis show higher Epstein-Barr virus (EBV) antibody titers compared to controls, suggesting a potential link and immune system dysregulation in MS patients.

Area of Science:

  • Immunology
  • Virology
  • Neurology

Background:

  • Epstein-Barr virus (EBV) establishes a lifelong latent infection.
  • Multiple sclerosis (MS) is a chronic neurological disease with suspected immune system involvement.

Purpose of the Study:

  • To investigate the association between serum antibody titers to Epstein-Barr virus (EBV) and multiple sclerosis (MS).
  • To explore potential immune system aberrations in MS patients related to EBV infection.

Main Methods:

  • Serum samples were collected from 157 MS patients and 81 healthy controls.
  • Antibody titers to EBV were quantified using serological assays.
  • Prevalence of high titers and geometric mean titers were compared between groups.

Main Results:

  • A significantly higher prevalence of high EBV antibody titers (≥1:160) was observed in MS patients (44.5%) compared to controls (28.9%).
  • The geometric mean EBV antibody titer was significantly elevated in MS patients (107.0) versus controls (77.1).
  • No correlation was found between EBV antibody titers and MS disease duration or activity.

Conclusions:

  • These findings support the hypothesis that individuals with MS exhibit altered immune responses.
  • Elevated EBV antibody titers in MS patients may indicate a role for EBV in the disease pathogenesis or reflect a broader immunological abnormality.